Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 10050, China.
Biol Pharm Bull. 2011;34(10):1631-4. doi: 10.1248/bpb.34.1631.
In our previous study, two synthetic thiophenes such as IMB-05 and IMB-15 were found as peroxisome proliferator-activated receptor gamma (PPARγ) agonists and exhibited beneficial effects on glucose tolerance of diabetic mice in vivo. In the present study, their effect on the transactivity of other nuclear receptors was further investigated. IMB-05 and IMB-15 could not only activated PPARγ but also efficiently activate PPARα in GAL4-hPPARα/γ (ligand binding domain (LBD)) chimeric receptor assay and PPAR response element (PPRE)-luc reporter gene assay with EC(50) values of 1.8-5.2 µM, whereas no activity was observed in other nuclear receptor assays. In addition, the maximal efficacy of IMB-05 and IMB-15 in activating PPARα/γ was approximately 30% of that observed with Wy14643 and rosiglitazone. These data indicate that the two thiophene derivatives are novel class of partial PPARα/γ dual agonists, which may be the mechanism underlying their regulatory effects on glucose homeostasis.
在我们之前的研究中,发现两种合成噻吩类化合物 IMB-05 和 IMB-15 是过氧化物酶体增殖物激活受体 γ (PPARγ) 激动剂,并在体内表现出对糖尿病小鼠葡萄糖耐量的有益作用。在本研究中,进一步研究了它们对其他核受体转录活性的影响。IMB-05 和 IMB-15 不仅可以激活 PPARγ,而且可以在 GAL4-hPPARα/γ(配体结合域(LBD))嵌合受体测定和 PPAR 反应元件(PPRE)-荧光素酶报告基因测定中有效地激活 PPARα,EC50 值为 1.8-5.2 μM,而在其他核受体测定中则没有活性。此外,IMB-05 和 IMB-15 激活 PPARα/γ 的最大功效约为 Wy14643 和罗格列酮的 30%。这些数据表明,这两种噻吩衍生物是新型的部分 PPARα/γ 双重激动剂,这可能是它们对葡萄糖稳态调节作用的机制。